Analysis of bovine leukemia virus Gag membrane targeting and late domain function

Journal of Virology

Volumn 76, Issue 16, 2002, Pages 8485-8493

  Wang, Huating ^a   Norris, Kendra M ^a   Mansky, Louis M ^a  

^a 2078 Graves Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCINE; MEMBRANE PROTEIN; PROTEIN PRECURSOR; PROTEINASE;

ARTICLE; BOVINE LEUKEMIA VIRUS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL SURFACE; ELECTRON MICROSCOPY; GENE OVEREXPRESSION; HUMAN T CELL LEUKEMIA VIRUS; MOLECULAR MODEL; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN TARGETING; RETROVIRUS; VIRUS ASSEMBLY; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATTLE; DNA, VIRAL; GENE PRODUCTS, GAG; GENES, GAG; HUMANS; LEUKEMIA VIRUS, BOVINE; MICROSCOPY, ELECTRON; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; VIRUS ASSEMBLY;

EID: 0036315329     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.16.8485-8493.2002     Document Type: Article

References (54)

1. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-1) Gag and Gag-Pro polyproteins from insect and mammalian cells
2. Myristoylation-dependent replication and assembly of human immunodeficiency virus I
3. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection
4. Retroviral matrix proteins: A structural perspective
5. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras
6. Over-expression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function
7. The late domain of human immunodeficiency virus type I p6 promotes virus release in a cell type-dependent manner
8. Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity
9. HIV-1 Gag proteins: Diverse functions in the virus life cycle
10. Viral late domains
11. Identification of retroviral late domains as determinants of particle size
12. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
13. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor
14. Retrovirus-like particles produced by vaccinia viruses expressing gag-pro-pol region genes of bovine leukaemia virus
15. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
16. Macromolecular interactions in the assembly of HIV and other retroviruses
17. Bovine leukemia virus Gag particle assembly in insect cells: Formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein
18. Partial inhibition of the human immunodeficiency virus type I protease results in aberrant virus assembly and the formation of noninfectious particles
19. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles
20. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells
21. Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission
22. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication
23. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene
24. The bovine leukemia virus encapsidation signal is composed of RNA secondary structures
25. The solution structure of the bovine leukemia virus matrix protein and similarity with lentiviral matrix proteins
26. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus
27. RNA is a structural element in retrovirus particles
28. Binding of human immunodeficiency virus type 1 Gag to membrane: Role of the matrix amino terminus
29. Characterization of human immunodeficiency virus type 1 matrix revertants: Effects on virus assembly, Gag processing, and Env incorporation into virions
30. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting
31. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins
32. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein
33. Ubiquitin is part of the retrovirus budding machinery
34. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein
35. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly
36. Ubiquitin in avian leukosis virus particles
37. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus
38. Retroviral RNA packaging: A review
39. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus
40. In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid
41. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism
42. Synthesis, assembly, and processing of viral proteins
43. Analysis of human lymphotropic T-cell virus type 2-like particle production by recombinant baculovirus-infected insect cells
44. Tsg1(11, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)
45. Ubiquitin in retrovirus assembly: Actor or bystander?
46. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release
47. An assembly domain of the Rous sarcoma virus Gag protein required late in budding
48. Form, function, and use of retroviral gag proteins
49. gag late assembly domain
50. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release
51. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses
52. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle
53. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids